The 3-month minimum protocol applies here expect sleep improvements first, followed by recovery and aesthetic benefits, with body composition changes becoming noticeable around months 23
In addition, Semaglutide and Tirzepatide are drugs that show the potential to improve metabolic health and reduce A1C hemoglobin
Compounding facilities typically blend the two peptides in 1:1 or 2:1 (Tesamorelin:Ipamorelin) ratios at total doses of 2mg Tesamorelin + 200300 mcg Ipamorelin per injection
These guidelines recommend a comprehensive strategy be followed to reduce risks of CKD in people living with T2DM and are summarized in Fig
Link to study While these medications are not yet licensed specifically to treat AF , the growing body of evidence suggests they may reduce the risk of developing AF and lower recurrence rates , particularly in people with obesity and type 2 diabetes
Talking to your healthcare provider can help ensure your safety and give you peace of mind about using both medications together